International Assets Investment Management LLC decreased its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 81.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 102,326 shares of the company’s stock after selling 436,250 shares during the quarter. Clorox makes up about 0.8% of International Assets Investment Management LLC’s portfolio, making the stock its 13th biggest holding. International Assets Investment Management LLC’s holdings in Clorox were worth $16,619,000 at the end of the most recent reporting period.
Other hedge funds have also recently modified their holdings of the company. Prospera Private Wealth LLC acquired a new stake in shares of Clorox during the 3rd quarter worth about $27,000. Trifecta Capital Advisors LLC increased its position in shares of Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after acquiring an additional 130 shares during the last quarter. Continuum Advisory LLC raised its stake in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares during the period. Quarry LP lifted its holdings in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after acquiring an additional 114 shares during the last quarter. Finally, Carolina Wealth Advisors LLC purchased a new position in shares of Clorox during the 3rd quarter worth approximately $48,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on CLX. Barclays boosted their target price on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research report on Friday, November 1st. Wells Fargo & Company raised Clorox from an “underweight” rating to an “equal weight” rating and increased their target price for the stock from $155.00 to $157.00 in a research note on Tuesday. DA Davidson lifted their target price on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and increased their price target for the stock from $174.00 to $187.00 in a research report on Tuesday, October 1st. Finally, StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $157.46.
Clorox Price Performance
CLX traded up $0.43 during midday trading on Wednesday, reaching $160.13. 109,948 shares of the company’s stock were exchanged, compared to its average volume of 887,935. The business’s 50-day moving average price is $164.64 and its 200 day moving average price is $155.33. The stock has a market capitalization of $19.82 billion, a PE ratio of 55.79, a P/E/G ratio of 3.04 and a beta of 0.42. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.
Clorox (NYSE:CLX – Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the prior year, the company earned $0.49 EPS. Clorox’s revenue was up 27.0% on a year-over-year basis. As a group, equities analysts anticipate that The Clorox Company will post 6.85 EPS for the current fiscal year.
Clorox Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.05%. Clorox’s dividend payout ratio (DPR) is currently 170.03%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- How to Find Undervalued Stocks
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
- Investing in Travel Stocks Benefits
- Cal-Maine Foods: A Defensive Play With a Cage-Free Future
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.